Cinvige Medical Unveils Full‑Chain Drug Delivery Solutions at CPHI China 2026
The 24th CPHI China 2026 was held at the Shanghai New International Expo Centre from June 16–18, 2026. The exhibition covered over 250,000 sqm, brought together more than 3,700 exhibitors, and attracted over 100,000 professional visitors.
Cinvige Medical presented its full-chain drug delivery solutions at the show, highlighting its series of products including Reusable Injection Pen,Disposable Cartridge Pen Injector,Disposable Auto Prefilled Pen Injector and Injection Pen Needle. The newly launched Disposable spring-driven Cartridge Pen Injector component enables automatic, uniform drug delivery, making it suitable for precise administration in chronic disease glycemic control, weight management, and peptide hormone therapies.
The company operates two major manufacturing bases in Linyi and Taizhou, with a total floor area of 65,812 sqm, ensuring large scale supply capacity: annual output of over 150 million Disposable Cartridge Pen Injector, over 6 million Reusable Injection Pen and over 10 million Disposable Auto Prefilled Pen Injector. Its products are now available in more than 20 countries and regions worldwide.
During the exhibition, Cinvige reached cooperation intentions with many new and existing customers, and effectively expanded its new client base in the EU, India, Southeast Asia, and other regions. The company will continue to deepen its core technology development and accelerate its global expansion.
